Evidence map›Paper›PMID 36290943›Full record

ArticleBiosensors2022

Clinical Application of Epithelial Sodium Channel (ENaC) as a Biomarker for Arterial Hypertension.

Diana García-Rubio, Ivette Martínez-Vieyra, Maria Beatriz de la Mora, Marco Antonio Fuentes-García, Doris Cerecedo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The Epithelial Sodium Channel-An Underestimated Drug Target.International journal of molecular sciences · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Diana García-RubioLaboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico City 07738, Mexico.ORCID 0000-0001-7324-539X
Ivette Martínez-VieyraLaboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico City 07738, Mexico.ORCID 0000-0002-4414-5469
Maria Beatriz de la MoraCONACyT Fellow-ICAT, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Marco Antonio Fuentes-GarcíaUnidad de Investigación, Instituto Mexicano el Seguro Social, Mexico City 06700, Mexico.
Doris CerecedoLaboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico City 07738, Mexico.
Instituto Politécnico Nacional · MXMexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MX

Funding

Secretaria de Educación, Ciencia, Tecnología e Innovación de la CDMX (SECTEI/281/2019)Secretaría de Investigación y Posgrado, IPN 20210517
6 · The paper itself

Abstract

Arterial hypertension (HTN) is a global public health concern and an important risk factor for cardiovascular diseases and renal failure. We previously reported overexpression of ENaC on the plasma membrane of human platelets is a hallmark of HTN. In this double-blinded study of an open population (

Indexed as

HypertensionMetal NanoparticlesBiomarkersEpithelial Sodium ChannelsGoldHumansBiomarkersEpithelial Sodium ChannelsGoldbioconjugatesgold nanoparticleshypertension diagnosisplatelets

Identifiers

PMID36290943
PMCPMC9599886
OpenAlexW4297988883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.